Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.

The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies ...

Amid the military posturing, economic sanctions, and political power struggles shaping the U.S.-China rivalry, intellectual property (IP) disputes remain a major battleground. In January 2025, Chinese ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced in Q4 CY2024, with sales up 7.5% year on year to $12.34 ...

BMS is not the only U.S. pharma giant making massive cuts. Last year, Pfizer revealed a similar plan to reduce $1.5 billion ...

But there were also invisible treasures—assets you couldn’t touch but which added immense value to businesses. These were things like patents, copyrights, brand value, or software. Businesses ...

Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast ...

The packaging machine supplier has developed a new drivetrain technology to boost productivity, energy efficiency.

An FCA patent application shows how future EVs could leverage hardware they already carry to make an onboard winch lighter ...

The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for six others. While this is expected to ...